This groundbreaking multi-cancer early detection test identifies a signal common to many cancers, including those without established screening tests. Clinical studies have demonstrated its ability to detect signals associated with over 50 types of cancer through a simple blood draw.

Key points to note:

● Currently, there are only five recommended cancer screening tests: breast, colorectal, lung (for those at risk), cervical, and prostate.
● Many cancers are often diagnosed too late, when symptoms surface in advanced stages. Early detection significantly increases the chances of successful treatment and survival.
● This test is designed to detect active cancer within your body but does not assess future genetic cancer risks.